Japan· JP-2478002F1070
メドロキシプロゲステロン酢酸エステル
A medicinal product containing メドロキシプロゲステロン酢酸エステル, registered in Japan by ファイザー, on the national reimbursement list.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- メドロキシプロゲステロン酢酸エステル
- Manufacturer
- ファイザー
- Country
- Japan (JP)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- September 25, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
メドロキシプロゲステロン酢酸エステル in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesDepo-ProveraPharmacia & Upjohn Company LLC
- United KingdomAdgyn Medro 5mg tabletsKyowa Kirin Ltd
- FinlandCykrinaWyeth Medica Ireland
- BelgiumDepo-Provera 1000, 1000 mgPfizer
- CzechiaDEPO-PROVERAPfizer, spol. s r.o., Praha
- CanadaAA-MEDROXYAA PHARMA INC
- NetherlandsDepo-Provera 150, suspensie voor injectie 150 mg/mlPfizer B.V.
- SwedenDepo-Provera 150 mg/ml Injektionsvätska, suspensionPfizer AB
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Depocon, Farlutal
- Belgium · Depo-Provera, Provera
- Bulgaria · Фарлутал
- Czechia · Depo-Provera, Provera
- Germany · Depo-Clinovir, Mpa
- Denmark · Depo-Provera, Provera
- Estonia · Farlutal
- Spain · Depo-Progevera, Progevera
- Finland · Farlutal, Provera
- France · Depo Prodasone, Depo Provera
- United Kingdom (Northern Ireland) · Depo-Provera, Medroxyprogesterone Acetate Pfizer
- Croatia · Provera
- Hungary · Depo-Provera, Provera
- Ireland · Depo-Provera, Provera
- Iceland · Depo-Provera
- Italy · Depo-Provera, Farlutal
- Luxembourg · Depo-Provera, Provera
- Latvia · Depo-Provera
- Netherlands · Depo-Provera, Provera
- Norway · Depo-Provera, Provera
- Poland · Depo-Provera, Provera
- Portugal · Depo-Provera 150
- Sweden · Depo-Provera, Provera
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f2d72916-5cac-43b3-85b4-334cb39ff543 GET /v1/drugs/f2d72916-5cac-43b3-85b4-334cb39ff543?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "２．５ｍｇ１錠",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "2478002F1070",
"category": "内用薬",
"price_yen": 14.9,
"generic_name": "メドロキシプロゲステロン酢酸エステル",
"product_name_jp": null,
"therapeutic_class": "2478",
"transitional_expiry": null
}See everything about メドロキシプロゲステロン酢酸エステル.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.